It is important for the public to be aware of the scope of ovarian cancer, as over 80% of patients will experience a recurrence of the disease. Kunle Odunsi, MD, PhD, the Director of the University of Chicago Medicine Comprehensive Cancer Center and CRI Scientific Advisory Council associate director, is an expert on ovarian cancer and a titan in the field of cancer immunotherapy research.
Immune to Cancer: The CRI Blog
Patient Immunotherapy Summit: Ovarian Cancer Brief
For media inquiries, please contact us at [email protected]
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
